We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
48 hedge funds and large institutions have $12.4M invested in Corvus Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more call options, than puts
Call options by funds: $40K | Put options by funds: $30K
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
2% more funds holding
Funds holding: 47 → 48 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7.54% less ownership
Funds ownership: 55.01% → 47.47% (-7.5%)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
33% less capital invested
Capital invested by funds: $18.5M → $12.4M (-$6.08M)
Holders
48
Holders Change
+1
Holders Change %
+2.13%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
10
Reduced
12
Closed
5
Calls
$40K
Puts
$30K
Net Calls
+$10K
Net Calls Change
-$10K
Top Buyers
| 1 |
CA
CHI Advisors
New York
|
+$162K |
| 2 |
Two Sigma Advisers
New York
|
+$102K |
| 3 |
Two Sigma Investments
New York
|
+$65.5K |
| 4 |
TI
Telemetry Investments
New York
|
+$59.1K |
| 5 |
B
Bailard
Foster City,
California
|
+$38.2K |
Top Sellers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$3.27M |
| 2 |
Millennium Management
New York
|
-$403K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$187K |
| 4 |
Goldman Sachs
New York
|
-$21.6K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$20.7K |
